Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.

Ogawa Y, Kawamura T, Matsuzawa T, Aoki R, Gee P, Yamashita A, Moriishi K, Yamasaki K, Koyanagi Y, Blauvelt A, Shimada S.

Cell Host Microbe. 2013 Jan 16;13(1):77-86. doi: 10.1016/j.chom.2012.12.002. Epub 2013 Jan 16.

2.

Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells.

Marsden V, Donaghy H, Bertram KM, Harman AN, Nasr N, Keoshkerian E, Merten S, Lloyd AR, Cunningham AL.

J Immunol. 2015 May 1;194(9):4438-45. doi: 10.4049/jimmunol.1401706. Epub 2015 Apr 3.

3.

Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.

de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB.

J Immunol. 2010 Aug 1;185(3):1633-41. doi: 10.4049/jimmunol.0904137. Epub 2010 Jun 30.

4.

Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation.

Puttur FK, Fernandez MA, White R, Roediger B, Cunningham AL, Weninger W, Jones CA.

J Immunol. 2010 Jul 1;185(1):477-87. doi: 10.4049/jimmunol.0904106. Epub 2010 Jun 2.

5.

R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms.

Kawamura T, Gulden FO, Sugaya M, McNamara DT, Borris DL, Lederman MM, Orenstein JM, Zimmerman PA, Blauvelt A.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8401-6. Epub 2003 Jun 18.

6.

Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages.

Sartori E, Calistri A, Salata C, Del Vecchio C, Palù G, Parolin C.

Virol J. 2011 Apr 12;8:166. doi: 10.1186/1743-422X-8-166.

7.

Functional HIV CXCR4 coreceptor on human epithelial Langerhans cells and infection by HIV strain X4.

Tchou I, Misery L, Sabido O, Dezutter-Dambuyant C, Bourlet T, Moja P, Hamzeh H, Peguet-Navarro J, Schmitt D, Genin C.

J Leukoc Biol. 2001 Aug;70(2):313-21.

PMID:
11493625
8.

Viruses and Langerhans cells.

Cunningham AL, Abendroth A, Jones C, Nasr N, Turville S.

Immunol Cell Biol. 2010 May-Jun;88(4):416-23. doi: 10.1038/icb.2010.42. Review.

PMID:
20445632
9.

TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB.

J Clin Invest. 2008 Oct;118(10):3440-52. doi: 10.1172/JCI34721.

10.

Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India.

Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, Divekar AD, Gangakhedkar RR, Ghate MV, Bollinger RC, Mehendale SM.

J Infect Dis. 2003 May 15;187(10):1513-21. Epub 2003 Apr 23.

PMID:
12721931
11.

Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection.

Zaitseva M, Blauvelt A, Lee S, Lapham CK, Klaus-Kovtun V, Mostowski H, Manischewitz J, Golding H.

Nat Med. 1997 Dec;3(12):1369-75.

PMID:
9396607
12.

The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.

Corey L, Wald A, Celum CL, Quinn TC.

J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435-45. Review.

PMID:
15021308
13.

Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation.

Ogawa Y, Kawamura T, Kimura T, Ito M, Blauvelt A, Shimada S.

Blood. 2009 May 21;113(21):5157-66. doi: 10.1182/blood-2008-10-185728. Epub 2009 Mar 11.

14.

HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa.

Sivard P, Berlier W, Picard B, Sabido O, Genin C, Misery L.

J Infect Dis. 2004 Jul 15;190(2):227-35. Epub 2004 Jun 14.

PMID:
15216455
15.

Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting.

Russell DB, Tabrizi SN, Russell JM, Garland SM.

J Clin Virol. 2001 Oct;22(3):305-13.

PMID:
11564596
16.

HIV-1 transmission in the male genital tract.

Ganor Y, Bomsel M.

Am J Reprod Immunol. 2011 Mar;65(3):284-91. doi: 10.1111/j.1600-0897.2010.00933.x. Epub 2010 Nov 28. Review.

PMID:
21114566
17.

Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.

Sabri F, Tresoldi E, Di Stefano M, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G.

Virology. 1999 Nov 25;264(2):370-84.

18.

Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.

Kawamura T, Cohen SS, Borris DL, Aquilino EA, Glushakova S, Margolis LB, Orenstein JM, Offord RE, Neurath AR, Blauvelt A.

J Exp Med. 2000 Nov 20;192(10):1491-500.

19.

Keratinocytes play a role in the immunity to Herpes simplex virus type 2 infection.

Shao Y, Zhang W, Dong X, Liu W, Zhang Ch, Zhang J, Zhong Q, Wu Q, Yang H, Chen Y, Wan J, Yu B.

Acta Virol. 2010;54(4):261-7.

PMID:
21175248
20.

Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides.

Rollenhagen C, Lathrop MJ, Macura SL, Doncel GF, Asin SN.

Mucosal Immunol. 2014 Sep;7(5):1165-74. doi: 10.1038/mi.2014.3. Epub 2014 Feb 5.

Supplemental Content

Support Center